EGF Theramed Health Corp. is a consumer technology company, which engages in the provision of biomedical online services for monitoring and treating common health problems. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-06-20. The firm is focused on the psilocybin space, looking at methods of improving delivery systems for the compound. The firm explores many other medical areas, including weight loss, skin care and heart disease. Its portfolio includes Pharmadelic Labs and Green Parrot Labs. Pharmadelic Labs is a biotech company focusing on improving and patenting engineering processes for the biosynthesis of compounds - primarily psilocybin, the psychoactive component of magic mushrooms. Green Parrot Labs is a Caribbean-based company focusing on research into psilocybin and establishing health centers dealing with treatment-resistant conditions. The firm is also actively exploring opportunities in all medical areas in domestic and international markets.
根据最新的财务报表(Form-10K),EGF Theramed Health Corp. 的总资产为 $0,净损失为 $-3
EVAHF 的关键财务比率是什么?
EGF Theramed Health Corp. 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
EGF Theramed Health Corp. 的收入按细分市场或地理位置如何划分?
EGF Theramed Health Corp. 最大收入来源是 Chinese Medicine and Healthcare Products,在最近的收益报告中收入为 1,560,767,000。就地区而言, Hong Kong 是 EGF Theramed Health Corp. 的主要市场,收入为 1,069,651,000。